BS EN ISO 11615:2012
$215.11
Health informatics. Identification of medicinal products. Data elements and structures for the unique identification and exchange of regulated medicinal product information
Published By | Publication Date | Number of Pages |
BSI | 2012 | 128 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
7 | Foreword |
8 | Introduction |
11 | 1 Scope 2 Normative references 3 Terms, definitions and abbreviations 3.1 Terms and definitions |
22 | 3.2 Abbreviations |
24 | 4 Requirements 4.1 Concepts required for the unique Identification of Medicinal Products |
27 | 5 Description of the information modelling principles and practices 5.1 General considerations |
28 | 5.2 Conceptual overview diagrams |
29 | 5.3 Section high-level diagrams |
30 | 5.4 Detailed description diagrams |
33 | 6 Identifying characteristics for authorized Medicinal Products 6.1 Primary identifiers 6.2 Medicinal Product Identifier (MPID) |
34 | 6.3 Packaged Medicinal Product Identifier (PCID) |
35 | 6.4 Medicinal Product Batch Identifier (BAID_1) 6.5 Medicinal Product Batch Identifier (BAID_2) 7 Information for an authorized Medicinal Product 7.1 Authorized Medicinal Product — Information overview |
37 | 7.2 Medicinal Product |
42 | 7.3 Marketing Authorization |
48 | 7.4 Organization |
50 | 7.5 Manufacturer/Establishment |
51 | 7.6 Packaged Medicinal Product, including Manufactured Item and Device |
60 | 7.7 Ingredient, Substance and Strength |
64 | 7.8 Pharmaceutical Product and Device |
68 | 7.9 Clinical Particulars |
76 | 8 Identifying characteristics for Investigational Medicinal Products 8.1 General 8.2 Primary identifiers |
77 | 8.3 Investigational Medicinal Product Identifier (IMPID) |
78 | 8.4 Investigational Medicinal Product Package Identifier (IPCID) 8.5 Investigational Medicinal Product Batch Identifier (IBAID_1) 8.6 Investigational Medicinal Product Batch Identifier (IBAID_2) |
79 | 9 Information for an Investigational Medicinal Product 9.1 Conceptual overview of the information for an Investigational Medicinal Product |
80 | 9.2 Investigational Medicinal Product |
82 | 9.3 Clinical Trial Authorization |
85 | 9.4 Manufacturer/Establishment 9.5 Investigational Packaged Medicinal Product |
86 | 9.6 Pharmaceutical Product |
87 | 9.7 Ingredient 9.8 Clinical particulars |
88 | Annex A (informative) Full model — Authorized Medicinal Products conceptual level |
89 | Annex B (informative) Full model — Authorized Medicinal Products detailed diagram |
90 | Annex C (informative) Full model — Investigational Medicinal Products conceptual level |
91 | Annex D (informative) Full Model — Investigational Medicinal Products detailed diagram |
92 | Annex E (informative) Worked example in tabular form |
101 | Annex F (informative) Class and attribute listing |
115 | Annex G (informative) Example implementation of Medicinal Product information |
123 | Bibliography |